PIP4K2A, phosphatidylinositol-5-phosphate 4-kinase type 2 alpha, 5305
N. diseases: 42; N. variants: 17
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.776 | 0.280 | 10 | 22550699 | missense variant | T/C | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
1.000 | 0.040 | 10 | 22541612 | intron variant | C/T | snv | 0.55 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
1.000 | 0.040 | 10 | 22536204 | 3 prime UTR variant | T/A;C | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
0.882 | 0.160 | 10 | 22550699 | missense variant | T/C | snv | 0.27 | 0.24 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2008 | 2009 | ||||||
|
1.000 | 0.040 | 10 | 22573558 | intron variant | C/A | snv | 0.27 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
1.000 | 0.040 | 10 | 22643562 | intron variant | T/A;C | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
1.000 | 0.080 | 10 | 22643219 | intron variant | T/C | snv | 0.27 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.120 | 10 | 22564019 | intron variant | C/A | snv | 0.55 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.030 | 0.667 | 3 | 2013 | 2016 | |||||||
|
0.776 | 0.280 | 10 | 22550699 | missense variant | T/C | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 2 | 2013 | 2018 | ||||||||
|
0.851 | 0.120 | 10 | 22564019 | intron variant | C/A | snv | 0.55 |
|
0.020 | 1.000 | 2 | 2013 | 2016 | ||||||||
|
0.851 | 0.120 | 10 | 22564019 | intron variant | C/A | snv | 0.55 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||||
|
0.776 | 0.280 | 10 | 22550699 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.776 | 0.280 | 10 | 22550699 | missense variant | T/C | snv |
|
0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
0.776 | 0.280 | 10 | 22550699 | missense variant | T/C | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.776 | 0.280 | 10 | 22550699 | missense variant | T/C | snv |
|
0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
0.776 | 0.280 | 10 | 22550699 | missense variant | T/C | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.120 | 10 | 22551654 | intron variant | C/T | snv | 0.55 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.120 | 10 | 22564173 | intron variant | T/C | snv | 0.57 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.851 | 0.120 | 10 | 22564019 | intron variant | C/A | snv | 0.55 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.120 | 10 | 22544224 | intron variant | G/A | snv | 0.66 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.776 | 0.280 | 10 | 22550699 | missense variant | T/C | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | < 0.001 | 1 | 2014 | 2014 | ||||||||
|
0.776 | 0.280 | 10 | 22550699 | missense variant | T/C | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders | 0.010 | < 0.001 | 1 | 2014 | 2014 | ||||||||
|
0.882 | 0.160 | 10 | 22550699 | missense variant | T/C | snv | 0.27 | 0.24 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | < 0.001 | 1 | 2014 | 2014 | ||||||
|
0.882 | 0.160 | 10 | 22550699 | missense variant | T/C | snv | 0.27 | 0.24 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders | 0.010 | < 0.001 | 1 | 2014 | 2014 | ||||||
|
1.000 | 10 | 22577963 | intron variant | T/C | snv | 0.82 |
|
0.010 | 1.000 | 1 | 2015 | 2015 |